What is the recommended management for a patient with mumps, considering their vaccination status and medical history?

Mumps Management

Mumps requires immediate isolation with droplet precautions for 5 days after parotitis onset, supportive care with NSAIDs or acetaminophen for symptom control, and vigilant monitoring for complications that are significantly more severe in adults than children. 1, 2, 3

Immediate Isolation and Infection Control

• Implement droplet precautions immediately upon diagnosis, as patients remain contagious from 7 days before through 8 days after parotitis onset 1, 2
• Isolate the patient for 5 days after parotitis begins to prevent transmission to susceptible contacts 1, 3
• Educate the patient and family that transmission occurs through respiratory droplets and direct contact with saliva 1, 2
• Report all probable or confirmed cases immediately to state and local health departments 3

Symptomatic Management

• Administer acetaminophen or NSAIDs for fever control, headache relief, and parotid gland pain 1, 2, 3
• Ensure adequate hydration and fluid intake, as parotitis makes swallowing uncomfortable and painful 1, 2, 3
• Recommend soft foods and instruct patients to avoid acidic foods that stimulate salivary flow and worsen parotid pain 1, 2, 3

Monitoring for Complications

Adults require heightened surveillance as complications are significantly more common and severe compared to children. 2, 3

Neurological Complications

• Watch for aseptic meningitis (occurs in 4-6% of cases) characterized by severe headache, neck stiffness, photophobia, or altered mental status 1, 2, 3
• Monitor for encephalitis signs including seizures, paralysis, or cranial nerve palsies, which can cause permanent neurological sequelae 1, 2, 3
• Assess for hearing loss, including sudden sensorineural deafness, which can be bilateral and permanent—this was a major cause of childhood deafness before vaccination 1, 2, 3

Reproductive System Complications

• In postpubertal males, assess for orchitis (occurs in up to 38% of cases) characterized by testicular pain and swelling, typically appearing approximately 10 days after parotitis 1, 2, 4
• Reassure patients that sterility is rare despite the high incidence of orchitis 1, 2
• In postpubertal females, monitor for oophoritis (ovarian inflammation) 1, 2

Other Systemic Complications

• Watch for pancreatitis characterized by severe abdominal pain, nausea, and vomiting 1, 2

Special Management: Facial Nerve Involvement

If facial nerve inflammation with weakness develops, initiate corticosteroid therapy promptly with prednisone 1-2 mg/kg/day for 5-7 days followed by a taper over 5-7 days. 1, 2, 3

• Provide eye protection to prevent corneal damage in patients with facial weakness who cannot completely close their eyes 1, 2, 3
• Reassure patients that complete recovery occurs in approximately 70-80% of cases within 3-6 months 1, 2

Post-Recovery Vaccination Considerations

• Adults born during or after 1957 without documentation of vaccination, laboratory evidence of immunity, or physician-diagnosed mumps should receive MMR vaccine after complete recovery 1
• A second dose of MMR is recommended for adults who live in communities experiencing mumps outbreaks, are students in postsecondary institutions, work in healthcare facilities, or plan international travel 1
• Do not administer MMR vaccine during acute illness; wait until recovery is complete 1
• Consider a third dose during outbreak settings for high-risk populations, though this is not routinely recommended by the CDC 1

Important Clinical Caveats

• Only 30-40% of mumps infections produce typical acute parotitis; 15-20% are asymptomatic and up to 50% present with nonspecific or respiratory symptoms 1, 2
• The disease is generally self-limiting, with most patients recovering without intervention beyond supportive care 1, 2
• Mumps can occur in highly vaccinated populations due to waning immunity, particularly in crowded environments like college dormitories—the 2006 U.S. outbreak demonstrated that 44% of cases occurred in persons who had received at least 2 doses of vaccine 1
• Laboratory confirmation is preferred over clinical diagnosis alone, as parotitis has multiple infectious and noninfectious causes 3

Management in Pregnancy

• Treatment in pregnant women follows the same supportive care principles with acetaminophen or NSAIDs for pain control, hydration, and soft foods 3
• MMR vaccine is contraindicated during pregnancy due to theoretical risk from live-virus vaccine 3
• Mumps infection during the first trimester increases risk for fetal death but is NOT associated with congenital malformations 3